
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $10.7B | $17.6B | $25.7B | $23.1B | $22.7B | |
Revenue Growth (YoY) | -35.47% | 64.3% | 46.22% | -10.34% | -1.63% | |
Cost of Revenues | $9.8B | $16.4B | $24.5B | $21.9B | $21B | |
Gross Profit | $867M | $1.2B | $1.2B | $1.2B | $1.7B | |
Gross Profit Margin | 8.1% | 6.67% | 4.61% | 5.11% | 7.62% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $173M | $168M | $183M | $194M | $349M | |
Other Inc / (Exp) | -$8M | -$18M | $18M | $19M | $604M | |
Operating Expenses | $448M | $438M | $521M | $550M | $894M | |
Operating Income | $419M | $735M | $665M | $628M | $836M | |
Net Interest Expenses | $175M | $163M | $182M | $217M | $391M | |
EBT. Incl. Unusual Items | $236M | $554M | $501M | $430M | $1B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $24M | $30M | $26M | $36M | $175M | |
Net Income to Company | $212M | $524M | $475M | $394M | $874M | |
Minority Interest in Earnings | -- | -- | -- | -- | -$8M | |
Net Income to Common Excl Extra Items | $135M | $446M | $397M | $311M | $716M | |
Basic EPS (Cont. Ops) | $1.63 | $5.35 | $4.74 | $3.70 | $6.04 | |
Diluted EPS (Cont. Ops) | $1.61 | $5.28 | $4.68 | $3.65 | $6.00 | |
Weighted Average Basic Share | $83.1M | $83.4M | $83.8M | $84.1M | $118.5M | |
Weighted Average Diluted Share | $83.7M | $84.4M | $84.8M | $85.1M | $119.3M | |
EBITDA | $595M | $887M | $870M | $829M | $1.8B | |
EBIT | $406M | $710M | $677M | $642M | $1.4B | |
Revenue (Reported) | $10.7B | $17.6B | $25.7B | $23.1B | $22.7B | |
Operating Income (Reported) | $419M | $735M | $665M | $628M | $836M | |
Operating Income (Adjusted) | $406M | $710M | $677M | $642M | $1.4B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $3.5B | $5.4B | $5.4B | $5.5B | $5.2B | |
Revenue Growth (YoY) | 6.08% | 55.63% | -0.74% | 2.56% | -5.82% | |
Cost of Revenues | $3.2B | $5B | $5B | $5.1B | $4.7B | |
Gross Profit | $304M | $383M | $327M | $441M | $497M | |
Gross Profit Margin | 8.76% | 7.09% | 6.1% | 8.02% | 9.6% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $39M | $43M | $45M | $54M | $55M | |
Other Inc / (Exp) | -$6M | $1M | $1M | $1M | $27M | |
Operating Expenses | $100M | $124M | $127M | $142M | $198M | |
Operating Income | $204M | $259M | $200M | $299M | $299M | |
Net Interest Expenses | $41M | $41M | $53M | $63M | $121M | |
EBT. Incl. Unusual Items | $157M | $219M | $148M | $237M | $205M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $3M | $3M | $7M | $7M | -$2M | |
Net Income to Company | $154M | $216M | $141M | $230M | $207M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $134M | $196M | $120M | $193M | $166M | |
Basic EPS (Cont. Ops) | $1.61 | $2.35 | $1.43 | $2.29 | $1.22 | |
Diluted EPS (Cont. Ops) | $1.60 | $2.32 | $1.41 | $2.26 | $1.21 | |
Weighted Average Basic Share | $83.3M | $83.7M | $84.1M | $84.4M | $136.3M | |
Weighted Average Diluted Share | $84.1M | $84.7M | $85M | $85.3M | $136.9M | |
EBITDA | $245M | $307M | $249M | $343M | $482M | |
EBIT | $198M | $260M | $201M | $300M | $326M | |
Revenue (Reported) | $3.5B | $5.4B | $5.4B | $5.5B | $5.2B | |
Operating Income (Reported) | $204M | $259M | $200M | $299M | $299M | |
Operating Income (Adjusted) | $198M | $260M | $201M | $300M | $326M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $10.9B | $19.5B | $25.7B | $23.2B | $22.4B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $9.8B | $18.3B | $24.6B | $21.9B | $20.6B | |
Gross Profit | $1.1B | $1.3B | $1.1B | $1.3B | $1.8B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $164M | $172M | $185M | $203M | $350M | |
Other Inc / (Exp) | -$13M | -$11M | $18M | $19M | $630M | |
Operating Expenses | $405M | $462M | $524M | $565M | $950M | |
Operating Income | $703M | $790M | $606M | $727M | $836M | |
Net Interest Expenses | $172M | $163M | $194M | $227M | $449M | |
EBT. Incl. Unusual Items | $518M | $616M | $430M | $519M | $1B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $24M | $30M | $30M | $36M | $166M | |
Net Income to Company | $494M | $586M | $400M | $483M | $851M | |
Minority Interest in Earnings | -- | -- | -- | -- | -$8M | |
Net Income to Common Excl Extra Items | $378M | $469M | $321M | $384M | $689M | |
Basic EPS (Cont. Ops) | $5.01 | $6.09 | $3.83 | $4.57 | $5.60 | |
Diluted EPS (Cont. Ops) | $4.97 | $6.00 | $3.78 | $4.49 | $5.55 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $876M | $949M | $812M | $923M | $1.9B | |
EBIT | $685M | $772M | $618M | $741M | $1.5B | |
Revenue (Reported) | $10.9B | $19.5B | $25.7B | $23.2B | $22.4B | |
Operating Income (Reported) | $703M | $790M | $606M | $727M | $836M | |
Operating Income (Adjusted) | $685M | $772M | $618M | $741M | $1.5B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $3.5B | $5.4B | $5.4B | $5.5B | $5.2B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $3.2B | $5B | $5B | $5.1B | $4.7B | |
Gross Profit | $304M | $383M | $327M | $441M | $497M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $39M | $43M | $45M | $54M | $55M | |
Other Inc / (Exp) | -$6M | $1M | $1M | $1M | $27M | |
Operating Expenses | $100M | $124M | $127M | $142M | $198M | |
Operating Income | $204M | $259M | $200M | $299M | $299M | |
Net Interest Expenses | $41M | $41M | $53M | $63M | $121M | |
EBT. Incl. Unusual Items | $157M | $219M | $148M | $237M | $205M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $3M | $3M | $7M | $7M | -$2M | |
Net Income to Company | $154M | $216M | $141M | $230M | $207M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $134M | $196M | $120M | $193M | $166M | |
Basic EPS (Cont. Ops) | $1.61 | $2.35 | $1.43 | $2.29 | $1.22 | |
Diluted EPS (Cont. Ops) | $1.60 | $2.32 | $1.41 | $2.26 | $1.21 | |
Weighted Average Basic Share | $83.3M | $83.7M | $84.1M | $84.4M | $136.3M | |
Weighted Average Diluted Share | $84.1M | $84.7M | $85M | $85.3M | $136.9M | |
EBITDA | $245M | $307M | $249M | $343M | $482M | |
EBIT | $198M | $260M | $201M | $300M | $326M | |
Revenue (Reported) | $3.5B | $5.4B | $5.4B | $5.5B | $5.2B | |
Operating Income (Reported) | $204M | $259M | $200M | $299M | $299M | |
Operating Income (Adjusted) | $198M | $260M | $201M | $300M | $326M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $97M | $25M | $82M | $29M | $94M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $239M | $428M | $755M | $703M | $1.1B | |
Inventory | $382M | $534M | $821M | $889M | $1.1B | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $62M | $95M | $175M | $133M | $141M | |
Total Current Assets | $847M | $1.2B | $2B | $1.9B | $2.5B | |
Property Plant And Equipment | $2B | $2.2B | $2.3B | $2.3B | $8.2B | |
Long-Term Investments | $136M | $132M | $129M | $124M | $1.3B | |
Goodwill | $1.6B | $1.6B | $1.6B | $1.6B | $1.5B | |
Other Intangibles | $588M | $542M | $588M | $544M | $547M | |
Other Long-Term Assets | $168M | $188M | $245M | $290M | $400M | |
Total Assets | $5.3B | $5.8B | $6.8B | $6.8B | $14.4B | |
Accounts Payable | $267M | $515M | $966M | $828M | $1.3B | |
Accrued Expenses | $100M | $83M | $104M | $115M | $192M | |
Current Portion Of Long-Term Debt | $6M | $6M | -- | -- | $2M | |
Current Portion Of Capital Lease Obligations | $19M | $19M | $21M | $22M | $34M | |
Other Current Liabilities | $47M | $56M | $42M | $56M | $96M | |
Total Current Liabilities | $653M | $890M | $1.4B | $1.4B | $1.9B | |
Long-Term Debt | $3.1B | $3.2B | $3.6B | $3.5B | $7.5B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $4.6B | $5B | $5.9B | $5.8B | $10.3B | |
Common Stock | -- | -- | -- | -- | -- | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $632M | $811M | $942M | $978M | $4.1B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $632M | $811M | $942M | $978M | $4.1B | |
Total Liabilities and Equity | $5.3B | $5.8B | $6.8B | $6.8B | $14.4B | |
Cash and Short Terms | $97M | $25M | $82M | $29M | $94M | |
Total Debt | $3.1B | $3.3B | $3.6B | $3.5B | $7.5B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $95M | $104M | $189M | $215M | $172M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $295M | $590M | $488M | $664M | $909M | |
Inventory | $430M | $704M | $768M | $953M | $1.1B | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $54M | $478M | $185M | $125M | $199M | |
Total Current Assets | $1B | $2B | $1.7B | $2.7B | $2.5B | |
Property Plant And Equipment | $1.9B | $2.2B | $2.3B | $2.3B | $8.1B | |
Long-Term Investments | $134M | $132M | $128M | $125M | $1.3B | |
Goodwill | $1.6B | $1.6B | $1.6B | $1.5B | $1.5B | |
Other Intangibles | $574M | $530M | $576M | $523M | $540M | |
Other Long-Term Assets | $172M | $196M | $258M | $278M | $435M | |
Total Assets | $5.4B | $6.6B | $6.6B | $7.4B | $14.3B | |
Accounts Payable | $427M | $705M | $730M | $1B | $1B | |
Accrued Expenses | $81M | $94M | $105M | $114M | $216M | |
Current Portion Of Long-Term Debt | $7M | -- | -- | -- | $2M | |
Current Portion Of Capital Lease Obligations | $19M | $19M | $21M | $23M | $31M | |
Other Current Liabilities | $52M | $57M | $36M | $193M | $81M | |
Total Current Liabilities | $754M | $1.1B | $1.2B | $1.6B | $1.6B | |
Long-Term Debt | $3.1B | $3.7B | $3.5B | $3.8B | $7.7B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $4.7B | $5.7B | $5.6B | $6.3B | $10.2B | |
Common Stock | -- | -- | -- | -- | -- | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $698M | $944M | $1B | $1.1B | $4.2B | |
Total Liabilities and Equity | $5.4B | $6.6B | $6.6B | $7.4B | $14.3B | |
Cash and Short Terms | $95M | $104M | $189M | $215M | $172M | |
Total Debt | $3.1B | $3.7B | $3.5B | $3.8B | $7.7B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $212M | $524M | $475M | $394M | $874M | |
Depreciation & Amoritzation | $189M | $177M | $193M | $187M | $368M | |
Stock-Based Compensation | $14M | $16M | $14M | $17M | $17M | |
Change in Accounts Receivable | $105M | -$232M | -$315M | $29M | -$192M | |
Change in Inventories | -$45M | $38M | -$172M | -$182M | -$265M | |
Cash From Operations | $502M | $543M | $561M | $600M | $549M | |
Capital Expenditures | $124M | $174M | $186M | $215M | $344M | |
Cash Acquisitions | -$20M | -$256M | -$318M | -$111M | $790M | |
Cash From Investing | -$120M | -$387M | -$464M | -$288M | $477M | |
Dividends Paid (Ex Special Dividend) | -$354M | -$357M | -$359M | -$371M | -$566M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $1.9B | $2.7B | $4.1B | $3.8B | $4.3B | |
Long-Term Debt Repaid | -$1.9B | -$2.6B | -$3.8B | -$3.8B | -$3.9B | |
Repurchase of Common Stock | -- | -- | -- | -- | -$784M | |
Other Financing Activities | -- | -- | -- | -$5M | -$27M | |
Cash From Financing | -$306M | -$228M | -$40M | -$365M | -$961M | |
Beginning Cash (CF) | $21M | $97M | $25M | $82M | $29M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $76M | -$72M | $57M | -$53M | $65M | |
Ending Cash (CF) | $97M | $25M | $82M | $29M | $94M | |
Levered Free Cash Flow | $378M | $369M | $375M | $385M | $205M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $154M | $216M | $141M | $230M | $207M | |
Depreciation & Amoritzation | $47M | $47M | $48M | $43M | $156M | |
Stock-Based Compensation | $4M | $5M | $5M | $4M | $4M | |
Change in Accounts Receivable | -$115M | -$200M | $315M | -$61M | $131M | |
Change in Inventories | $52M | -$50M | $82M | $53M | $18M | |
Cash From Operations | $152M | $23M | $326M | $286M | $156M | |
Capital Expenditures | $18M | $26M | $37M | $41M | $101M | |
Cash Acquisitions | -- | -$264M | -- | -$185M | -$36M | |
Cash From Investing | -$9M | -$285M | -$31M | -$223M | -$101M | |
Dividends Paid (Ex Special Dividend) | -$88M | -$88M | -$88M | -$91M | -$159M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $472M | $1.4B | $759M | $889M | $2.1B | |
Long-Term Debt Repaid | -$529M | -$1B | -$859M | -$675M | -$1.9B | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -$12M | |
Cash From Financing | -$145M | $341M | -$188M | $123M | $23M | |
Beginning Cash (CF) | $97M | $25M | $82M | $29M | $94M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$2M | $79M | $107M | $186M | $78M | |
Ending Cash (CF) | $95M | $104M | $189M | $215M | $172M | |
Levered Free Cash Flow | $134M | -$3M | $289M | $245M | $55M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $494M | $586M | $400M | $483M | $851M | |
Depreciation & Amoritzation | $191M | $177M | $194M | $182M | $481M | |
Stock-Based Compensation | $14M | $17M | $14M | $16M | $17M | |
Change in Accounts Receivable | -$248M | -$317M | $200M | -$347M | -- | |
Change in Inventories | -$3M | -$64M | -$40M | -$211M | -$300M | |
Cash From Operations | $616M | $414M | $864M | $560M | $419M | |
Capital Expenditures | $101M | $182M | $197M | $219M | $404M | |
Cash Acquisitions | -$16M | -$520M | -$54M | -$296M | $939M | |
Cash From Investing | -$89M | -$663M | -$210M | -$480M | $599M | |
Dividends Paid (Ex Special Dividend) | -$354M | -$357M | -$359M | -$374M | -$634M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $2B | $3.7B | $3.4B | $3.9B | $5.5B | |
Long-Term Debt Repaid | -$2.1B | -$3.1B | -$3.7B | -$3.6B | -$5.1B | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -$39M | |
Cash From Financing | -$463M | $258M | -$569M | -$54M | -$1.1B | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $64M | $9M | $85M | $26M | -$43M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $515M | $232M | $667M | $341M | $15M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $154M | $216M | $141M | $230M | $207M | |
Depreciation & Amoritzation | $47M | $47M | $48M | $43M | $156M | |
Stock-Based Compensation | $4M | $5M | $5M | $4M | $4M | |
Change in Accounts Receivable | -$115M | -$200M | $315M | -$61M | $131M | |
Change in Inventories | $52M | -$50M | $82M | $53M | $18M | |
Cash From Operations | $152M | $23M | $326M | $286M | $156M | |
Capital Expenditures | $18M | $26M | $37M | $41M | $101M | |
Cash Acquisitions | -- | -$264M | -- | -$185M | -$36M | |
Cash From Investing | -$9M | -$285M | -$31M | -$223M | -$101M | |
Dividends Paid (Ex Special Dividend) | -$88M | -$88M | -$88M | -$91M | -$159M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $472M | $1.4B | $759M | $889M | $2.1B | |
Long-Term Debt Repaid | -$529M | -$1B | -$859M | -$675M | -$1.9B | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -$12M | |
Cash From Financing | -$145M | $341M | -$188M | $123M | $23M | |
Beginning Cash (CF) | $97M | $25M | $82M | $29M | $94M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$2M | $79M | $107M | $186M | $78M | |
Ending Cash (CF) | $95M | $104M | $189M | $215M | $172M | |
Levered Free Cash Flow | $134M | -$3M | $289M | $245M | $55M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.